{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:54:04Z","timestamp":1760403244283,"version":"build-2065373602"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"DOI":"10.1007\/s11481-025-10249-8","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T03:58:16Z","timestamp":1760327896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurological Adverse Events from COVID-19 Vaccination and It\u2019s Associated Factors in Burkina Faso: Analysis of Spontaneous Reports from the National Database of Pharmacovigilance from 2021 to 2023"],"prefix":"10.1007","volume":"20","author":[{"given":"Alfred Anselme","family":"Dabilgou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emile Wendni","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Marie Adeline Wendlamita","family":"Kyelem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alassane","family":"Drav\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousmane","family":"Wanr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christain","family":"Napon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanase","family":"Millogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"10249_CR1","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.12669\/pjms.37.7.4522","volume":"37","author":"S Abbas","year":"2021","unstructured":"Abbas S, Abbas B, Amir S, Wajahat M (2021) Evaluation of adverse effects with COVID-19 vaccination in Pakistan. Pak J Med Sci 37:1959\u20131964","journal-title":"Pak J Med Sci"},{"key":"10249_CR2","unstructured":"African Union, Africa Centres for Disease Control. COVID-19 vaccination. Africa CDC Vaccine Dashboard. Available from: https:\/\/africacdc.org\/covid-19-vaccination\/ [accessed 26 November 2022."},{"key":"10249_CR3","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.3390\/vaccines10122089","volume":"10","author":"A Alhossan","year":"2022","unstructured":"Alhossan A, Alsaran AK, Almahmudi AH, Aljohani ZS, Albishi MR, Almutairi AK (2022) Adverse Events of COVID-19 Vaccination among the Saudi Population: A Systematic Review and Meta-Analysis. Vaccines 10:2089","journal-title":"Vaccines"},{"key":"10249_CR4","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2147\/IDR.S394602","volume":"16","author":"S Alqatari","year":"2023","unstructured":"Alqatari S, Ismail M, Hasan M, Bukhari R, Al Argan R, Alwaheed A et al (2023) Emergence of Post COVID-19 Vaccine Autoimmune Diseases: A single-centre study. Infect Drug Resist 16:1263\u20131278","journal-title":"Infect Drug Resist"},{"issue":"5","key":"10249_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384(5):403\u2013416","journal-title":"N Engl J Med"},{"key":"10249_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.40364","volume":"4","author":"AL Beatty","year":"2021","unstructured":"Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Lin F, Olgin JE et al (2021) Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open 4:e2140364.35,36","journal-title":"JAMA Netw Open"},{"key":"10249_CR7","unstructured":"Burkina Faso - COVID 19 Rapport de situation - Burkina Faso Open Data. Disponible sur: https:\/\/burkinafaso.opendataforafrica.org\/jovpdge\/burkina-faso-covid-19-rapport-de-situation."},{"issue":"1","key":"10249_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2020.4596","volume":"46","author":"D Calina","year":"2020","unstructured":"Calina D, Docea AO, Petrakis D et al (2020) Towards effective COVID-19 vaccines: updates, perspectives and challenges (Review). Int J Mol Med 46(1):3\u201316","journal-title":"Int J Mol Med"},{"issue":"1","key":"10249_CR9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nrl.2022.09.005","volume":"40","author":"RA Castillo","year":"2022","unstructured":"Castillo RA, Castrillo JCM (2022) Neurological manifestations associated with the COVID-19 vaccine. Neurologia (Engl Ed) 40(1):66\u201376","journal-title":"Neurologia (Engl Ed)"},{"key":"10249_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-022-01247-x","volume":"23","author":"A Chatterjee","year":"2023","unstructured":"Chatterjee A, Chakravarty A (2023) Neurological complications following COVID19 vaccination. Curr Neurol Neurosci Rep 23:1\u201314","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10249_CR11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jamda.2023.04.003","volume":"24","author":"ECL Cheung","year":"2023","unstructured":"Cheung ECL, Leung MTY, Chen K, Wan EYF, Li X, Lai FTT et al (2023) Risk of adverse events and delirium after COVID-19 vaccination in patients living with dementia. J Am Med Dir Assoc 24:892","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"10249_CR12","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.37871\/jbres1389","volume":"2","author":"M Chileshe","year":"2021","unstructured":"Chileshe M, Mupeta G, Kasanga M, Mfune RL, Mudenda S, Biemba M, Shimaponda-Mataa NM, Sinkala M, Daka V (2021) Prevalence of adverse events post-COVID-19 vaccination amongst the adult Zambian population. J Biomed Res Environ Sci 2(12):1315\u20131321","journal-title":"J Biomed Res Environ Sci"},{"key":"10249_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105906","volume":"30","author":"L Dias","year":"2021","unstructured":"Dias L, Soares-Dos-Reis R, Meira J et al (2021) Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. J Stroke Cerebrovasc Dis 30:105906","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10249_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/diagnostics11040579","volume":"11","author":"B Doroftei","year":"2021","unstructured":"Doroftei B, Ciobica A, Ilie OD, Maftei R, Ilea C (2021) Discussing the reliability and efficiency of COVID-19 vaccines. Diagnostics 11:579","journal-title":"Diagnostics"},{"key":"10249_CR15","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.neurol.2022.02.282","volume":"178","author":"B Douma","year":"2022","unstructured":"Douma B, Anis H, Jemai K, Asma N, Salma N, Amor SB (2022) Les manifestations neurologiques post-vaccination Covid-19: cons\u00e9quence ou co\u00efncidence? Rev Neurol (Paris) 178:S71","journal-title":"Rev Neurol (Paris)"},{"key":"10249_CR16","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S379204","author":"M Farhat","year":"2022","unstructured":"Farhat M et al (2022) Study of the side effects of Pfizer and Oxford COVID-19 vaccines in the eastern province of Saudi Arabia. Int J Gen Med. https:\/\/doi.org\/10.2147\/IJGM.S379204","journal-title":"Int J Gen Med"},{"key":"10249_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ane.13550","volume":"145","author":"J Finsterer","year":"2022","unstructured":"Finsterer J (2022) Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurol Scand 145:5\u20139","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10249_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/v13030418","volume":"13","author":"CD Funk","year":"2021","unstructured":"Funk CD, Laferri\u00e8re C, Ardakani A (2021) Target product profile analysis of COVID-19 vaccines in phase III clinical trials and beyond: an early 2021 perspective. Viruses 13(3):418","journal-title":"Viruses"},{"key":"10249_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.876336","volume":"10","author":"S Ganesan","year":"2022","unstructured":"Ganesan S, Al Ketbi LMB, Al Kaabi N, Al Mansoori M, Al Maskari NN, Al Shamsi MS et al (2022) Vaccine side effects following COVID-19 vaccination among the residents of the UAE-an observational study. Front Public Health 10:876336","journal-title":"Front Public Health"},{"key":"10249_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108786","volume":"229","author":"M Garc\u00eda-Grimshaw","year":"2021","unstructured":"Garc\u00eda-Grimshaw M, Ceballos-Liceaga SE, Hern\u00e1ndez-Vanegas LE, N\u00fa\u00f1ez I, Hern\u00e1ndez-Valdivia N, Carrillo-Garc\u00eda DA et al (2021) Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study. Clin Immunol 229:108786","journal-title":"Clin Immunol"},{"issue":"8","key":"10249_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","volume":"70","author":"J Gee","year":"2021","unstructured":"Gee J, Marquez P, Su J, Calvert GM, Liu R, Myers T et al (2021) First month of COVID-19 vaccine safety monitoring - United States. MMWR Morb Mortal Wkly Rep 70(8):283\u2013288","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10249_CR22","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ana.26065","volume":"89","author":"AL Goss","year":"2021","unstructured":"Goss AL, Samudralwar RD, Das RR et al (2021) ANA Investigates: neurological complications of COVID-19 vaccines. Ann Neurol 89:856\u2013885","journal-title":"Ann Neurol"},{"key":"10249_CR23","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/aphw.12411","volume":"15","author":"Q Han","year":"2022","unstructured":"Han Q, Zheng B, Abakoumkin G, Leander NP, Stroebe W (2022) Why some people do not get vaccinated against COVID-19: social-cognitive determinants of vaccination behavior. Appl Psychol Health Well-Being 15:825\u2013845","journal-title":"Appl Psychol Health Well-Being"},{"issue":"2","key":"10249_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/npmj.npmj_11_22","volume":"29","author":"AM Harry","year":"2022","unstructured":"Harry AM, Edet CK, Ekanem NE, Kemdirim CJ, Uduak AE (2022) Adverse events following COVID-19 vaccination in Rivers State, Nigeria: a cross-sectional study. Niger Postgrad Med J 29(2):89\u201395","journal-title":"Niger Postgrad Med J"},{"issue":"8","key":"10249_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/vaccines9080911","volume":"9","author":"MA Hoffmann","year":"2021","unstructured":"Hoffmann MA, Wieler HJ, Enders P, Buchholz HG, Plachter B (2021) Age- and Sex-Graded Data Evaluation of Vaccination Reactions after Initial Injection of the BNT162b2 mRNA Vaccine in a Local Vaccination Center in Germany. Vaccines 9(8):911","journal-title":"Vaccines"},{"key":"10249_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13690-021-00741-x","volume":"79","author":"YR Konu","year":"2021","unstructured":"Konu YR, Gbeasor-Komlanvi FA, Yerima M, Sadio AJ, Tchankoni MK, Zida Compaore WI et al (2021) Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021. Archiv Public Health 79:1\u20139","journal-title":"Archiv Public Health"},{"issue":"2","key":"10249_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2174\/1574886318666230503113713","volume":"19","author":"B Moukafih","year":"2024","unstructured":"Moukafih B, Belaroussi L, Achour S, Kartouti AE (2024) Side effects reported by Moroccan medical students who received COVID-19 vaccines. Curr Drug Saf 19(2):268\u2013276","journal-title":"Curr Drug Saf"},{"issue":"1","key":"10249_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2176066","volume":"19","author":"SV Nguyen","year":"2023","unstructured":"Nguyen SV, Nguyen BT, Duong HNV, Lenh PT, Tran KT, Tran HM et al (2023) Side effects following first dose of COVID-19 vaccination in Ho Chi Minh City, Vietnam. Hum Vaccin Immunother 19(1):2176066","journal-title":"Hum Vaccin Immunother"},{"issue":"22","key":"10249_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192215303","volume":"19","author":"J Onyango","year":"2022","unstructured":"Onyango J, Mukunya D, Napyo A, Nantale R, Makoko BT, Matovu JK et al (2022) Side-effects following Oxford\/AstraZeneca COVID-19 vaccine in Tororo district, eastern Uganda: a cross-sectional study. Int J Environ Res Public Health 19(22):15303","journal-title":"Int J Environ Res Public Health"},{"key":"10249_CR30","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/jmv.27655","volume":"94","author":"SP Parida","year":"2022","unstructured":"Parida SP, Sahu DP, Singh AK et al (2022) Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India. J Med Virol 94:2453\u20132459","journal-title":"J Med Virol"},{"issue":"27","key":"10249_CR31","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383(27):2603\u20132615","journal-title":"N Engl J Med"},{"key":"10249_CR32","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","volume":"396","author":"MN Ramasamy","year":"2020","unstructured":"Ramasamy MN, Minassian AM, Ewer KJ et al (2020) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial. Lancet 396:1979\u20131993","journal-title":"Lancet"},{"issue":"12","key":"10249_CR33","first-page":"e33139","volume":"14","author":"M Riyyan","year":"2022","unstructured":"Riyyan M, Sajid S, Hotwani S, Chania HA, Shaikh MS, Sadiq Y et al (2022) Multimorbidity and Its Effect on Self-Reported Adverse Effects Following COVID-19 Vaccination. Cureus 14(12):e33139","journal-title":"Cureus"},{"issue":"10","key":"10249_CR34","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/vaccines11101621","volume":"11","author":"M Salsone","year":"2023","unstructured":"Salsone M, Signorelli C, Oldani A, Alberti VF, Castronovo V, Mazzitelli S et al (2023) NEURO-COVAX: an Italian population-based study of neurological complications after COVID-19 vaccinations. Vaccines 11(10):1621","journal-title":"Vaccines"},{"issue":"6","key":"10249_CR35","first-page":"149","volume":"35","author":"R Sawadogo","year":"2023","unstructured":"Sawadogo R, Ouoba J, Ilboudo D et al (2023) Manifestations post-vaccinales ind\u00e9sirables rapport\u00e9es avec les vaccins anti-COVID-19 au Burkina Faso\u202f: analyse des notifications spontan\u00e9es. Sant\u00e9 Publique 35(6):149\u201359","journal-title":"Sant\u00e9 Publique"},{"key":"10249_CR36","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","volume":"384","author":"NH Schultz","year":"2021","unstructured":"Schultz NH, Srvoll IH, Michelsen AE et al (2021) Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 384:2124\u20132130","journal-title":"N Engl J Med"},{"key":"10249_CR37","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2021.7517","volume":"325","author":"I See","year":"2021","unstructured":"See I, Su JR, Lale A et al (2021) US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, march 2 to april 21, 2021. JAMA 325:2448","journal-title":"JAMA"},{"issue":"12","key":"10249_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278334","volume":"17","author":"MT Segni","year":"2022","unstructured":"Segni MT, Demissie HF, Adem MK, Geleto AK, Kelkile MW, Sori BK et al (2022) Post COVID-19 vaccination side effects and associated factors among vaccinated health care providers in Oromia region, Ethiopia in 2021. PLoS ONE 17(12):e0278334","journal-title":"PLoS ONE"},{"key":"10249_CR39","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.2147\/JMDH.S331140","volume":"14","author":"Y Solomon","year":"2021","unstructured":"Solomon Y, Eshete T, Mekasha B, Assefa W (2021) COVID-19 vaccine: side effects after the first dose of the Oxford AstraZeneca vaccine among health professionals in low-income country: Ethiopia. J Multidiscip Healthc 14:2577\u20132585","journal-title":"J Multidiscip Healthc"},{"key":"10249_CR40","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1111\/jth.15352","volume":"19","author":"IH S\u00f8rvoll","year":"2021","unstructured":"S\u00f8rvoll IH, Horvei KD, Ernstsen SL et al (2021) An observational study to identify the prevalence of thrombocytopenia and anti-PF4\/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination. J Thromb Haemost 19:1813\u20131818","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10249_CR41","first-page":"2","volume":"24","author":"M Tounkara","year":"2023","unstructured":"Tounkara M, Coulibaly S, Diarra A, Diallo M, Samake S, Sow F et al (2023) Clinical side effects after the administration of the first dose of vaccine against COVID-19 in Bamako. Health Sci Dis 24(8):2","journal-title":"Health Sci Dis"},{"key":"10249_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4038\/cmj.v66i4.9508","volume":"66","author":"C Undugodage","year":"2021","unstructured":"Undugodage C, Dissanayake U, Kumara H, Samarasekera B, Yapa L, Ganegma R et al (2021) Reactogenicity to ChAdOx1nCoV-19 vaccine in health care workers: a multicenter observational study in Sri Lanka. Ceylon Med J 66:177\u2013184","journal-title":"Ceylon Med J"},{"key":"10249_CR43","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","volume":"333","author":"R Verbele","year":"2021","unstructured":"Verbele R, Lentacker I, De Smedt SC, Dewitte H (2021) The dawn of mRNA vaccines: The COVID-19 case. J Control Release 333:511\u2013520","journal-title":"J Control Release"},{"key":"10249_CR44","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.11.03104","volume":"11","author":"TN Vilches","year":"2021","unstructured":"Vilches TN, Sah P, Abdollahi E, Moghadas SM, Galvani AP (2021) Importance of non-pharmaceutical interventions in the COVID-19 vaccination era: a case study of the Seychelles. J Glob Health 11:03104","journal-title":"J Glob Health"},{"key":"10249_CR45","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","volume":"383","author":"EE Walsh","year":"2020","unstructured":"Walsh EE, Frenck RW Jr, Falsey AR et al (2020) Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates. N Engl J Med 383:2439\u20132450","journal-title":"N Engl J Med"},{"issue":"4","key":"10249_CR46","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jamapediatrics.2022.6243","volume":"177","author":"A Watanabe","year":"2023","unstructured":"Watanabe A, Kani R, Iwagami M, Takagi H, Yasuhara J, Kuno T (2023) Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years: a systematic review and meta-analysis. JAMA Pediatr 177(4):384\u2013394","journal-title":"JAMA Pediatr"},{"key":"10249_CR47","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","volume":"22","author":"J Watson","year":"2022","unstructured":"Watson J, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC (2022) Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis 22:1293\u20131302","journal-title":"Lancet Infect Dis"},{"key":"10249_CR48","unstructured":"WHO. Covid vaccination in the WHO african region. Monthly Bulletin July, 2022."},{"issue":"10228","key":"10249_CR49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(20)30557-2","volume":"395","author":"Y Wu","year":"2020","unstructured":"Wu Y, Ho W, Huang Y et al (2020) SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet 395(10228):949\u2013950","journal-title":"Lancet"},{"issue":"7","key":"10249_CR50","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/jmv.25813","volume":"92","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J, Fu J, Shang S, Shu Q, Zhang T (2020) Epidemiological analysis of COVID-19 and practical experience from China. J Med Virol 92(7):755\u2013769","journal-title":"J Med Virol"},{"key":"10249_CR51","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00701-021-04860-w","volume":"163","author":"Z Zakaria","year":"2021","unstructured":"Zakaria Z, Sapiai NA, Ghani ARI (2021) Cerebral venous sinus thrombosis 2 weeks after the first dose of the SARS-CoV-2 mRNA vaccine. Acta Neurochir 163:2359\u20132362","journal-title":"Acta Neurochir"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10249-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-025-10249-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10249-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T16:06:22Z","timestamp":1760371582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-025-10249-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10249"],"URL":"https:\/\/doi.org\/10.1007\/s11481-025-10249-8","relation":{},"ISSN":["1557-1904"],"issn-type":[{"type":"electronic","value":"1557-1904"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We had the permission of the Ethics Board of the School of the University Joseph KI-ZERBO and of the Director of the National Department of Pharmacovigilance in Burkina Faso. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publication Consent of the Participants"}},{"value":"All authors of the manuscript have read and agreed on its content and are responsible for all aspects of the accuracy and integrity of the manuscript in accordance with the ICMJE criteria.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors certify that they have no affiliations with or involvement in any organisation or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}}],"article-number":"89"}}